Price (delayed)
$5.7538
Market cap
$89.36M
P/E Ratio
N/A
Dividend/share
N/A
EPS
N/A
Enterprise value
$87.8M
The Company is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer’s disease (“Alzheimer’s disease” or “AD”), for which there are limited or
There are no recent dividends present for ACOG.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.